×
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity
Hmedat ANA., Doondeea J., Ebner D., Feller SM., Lewitzky M.
DOI
10.1101/2024.10.16.618664
Type
Preprint
Publication Date
18/10/2024